4-112514874-A-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The ENST00000313341.4(NEUROG2):āc.602T>Cā(p.Leu201Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000331 in 1,600,632 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
ENST00000313341.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NEUROG2 | NM_024019.4 | c.602T>C | p.Leu201Pro | missense_variant | 2/2 | ENST00000313341.4 | NP_076924.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NEUROG2 | ENST00000313341.4 | c.602T>C | p.Leu201Pro | missense_variant | 2/2 | 1 | NM_024019.4 | ENSP00000317333 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152004Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000265 AC: 6AN: 226620Hom.: 0 AF XY: 0.0000323 AC XY: 4AN XY: 123746
GnomAD4 exome AF: 0.0000338 AC: 49AN: 1448510Hom.: 1 Cov.: 29 AF XY: 0.0000264 AC XY: 19AN XY: 720172
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152122Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74376
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 02, 2023 | The c.602T>C (p.L201P) alteration is located in exon 2 (coding exon 1) of the NEUROG2 gene. This alteration results from a T to C substitution at nucleotide position 602, causing the leucine (L) at amino acid position 201 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at